Drug intelligence / Profile preview

apigenin 3-acetate

Development stage
Preclinical
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01

Overview

Apigenin 3-acetate is a semi-synthetic derivative of the natural flavonoid apigenin, in which an acetyl group is introduced at the 3-position of the molecule. Like its parent compound, it belongs to the class of flavones and exhibits bioactive properties. Preclinical studies have compared apigenin 3-acetate with both unmodified apigenin and methylprednisolone for their effects on immune cell proliferation and gene expression, particularly in Th1 cells relevant to autoimmune diseases such as multiple sclerosis. Apigenin derivatives are generally known for anti-inflammatory, antioxidant, antiproliferative, and immunomodulatory activities; however, specific mechanistic data for apigenin 3-acetate remain limited. The modification may alter pharmacokinetic or pharmacodynamic properties compared to native apigenin[9].

Other names
apigenin-3-acetateapigenin3-acetateapigenin 3-acetate3-O-acetylapigenin
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on apigenin 3-acetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on apigenin 3-acetate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call